Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:529254rdf:typepubmed:Citationlld:pubmed
pubmed-article:529254lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:529254lifeskim:mentionsumls-concept:C0001617lld:lifeskim
pubmed-article:529254lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:529254lifeskim:mentionsumls-concept:C0035544lld:lifeskim
pubmed-article:529254lifeskim:mentionsumls-concept:C0026272lld:lifeskim
pubmed-article:529254lifeskim:mentionsumls-concept:C0700364lld:lifeskim
pubmed-article:529254pubmed:issue6lld:pubmed
pubmed-article:529254pubmed:dateCreated1980-4-17lld:pubmed
pubmed-article:529254pubmed:abstractTextAntibodies to ribonucleoprotein are the serological marker of mixed connective tissue disease (MCTD). Five patients are presented who had negative or low titer anti-RNP antibodies despite characteristic MCTD. In all 5 patients antibodies to RNP appeared after they had taken prednisone for periods ranging from 3 wk to 15 months.lld:pubmed
pubmed-article:529254pubmed:languageenglld:pubmed
pubmed-article:529254pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:529254pubmed:citationSubsetIMlld:pubmed
pubmed-article:529254pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:529254pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:529254pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:529254pubmed:statusMEDLINElld:pubmed
pubmed-article:529254pubmed:issn0315-162Xlld:pubmed
pubmed-article:529254pubmed:authorpubmed-author:Alarcon-Segov...lld:pubmed
pubmed-article:529254pubmed:issnTypePrintlld:pubmed
pubmed-article:529254pubmed:volume6lld:pubmed
pubmed-article:529254pubmed:ownerNLMlld:pubmed
pubmed-article:529254pubmed:authorsCompleteYlld:pubmed
pubmed-article:529254pubmed:pagination694-9lld:pubmed
pubmed-article:529254pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:529254pubmed:meshHeadingpubmed-meshheading:529254-H...lld:pubmed
pubmed-article:529254pubmed:meshHeadingpubmed-meshheading:529254-A...lld:pubmed
pubmed-article:529254pubmed:meshHeadingpubmed-meshheading:529254-F...lld:pubmed
pubmed-article:529254pubmed:meshHeadingpubmed-meshheading:529254-R...lld:pubmed
pubmed-article:529254pubmed:meshHeadingpubmed-meshheading:529254-A...lld:pubmed
pubmed-article:529254pubmed:meshHeadingpubmed-meshheading:529254-A...lld:pubmed
pubmed-article:529254pubmed:meshHeadingpubmed-meshheading:529254-M...lld:pubmed
pubmed-article:529254pubmed:meshHeadingpubmed-meshheading:529254-M...lld:pubmed
pubmed-article:529254pubmed:articleTitleMixed connective tissue disease. Appearance of antibodies to ribonucleoprotein following corticosteroid treatment.lld:pubmed
pubmed-article:529254pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:529254pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:529254lld:pubmed